Sarecycline-containing product in oral dose form   781652004

SNOMED CT code


SNOMED code781652004
nameSarecycline-containing product in oral dose form
statusactive
date introduced2019-01-31
fully specified name(s)Product containing sarecycline in oral dose form (medicinal product form)
synonymsSarecycline-containing product in oral dose form
attributes - group0
Has manufactured dose formOral dose form   385268001
Plays roleAntiacne therapeutic role   773837006
Plays roleAntibacterial therapeutic role   787994008
attributes - group1
Has active ingredientSarecycline   781643008
parents
childrenSarecycline only product in oral dose form   781653009
hierarchies
a selection of possible paths
SNOMED CT Concept   138875005
  Pharmaceutical / biologic product   373873005
    Medicinal product   763158003
      Product manufactured as oral dose form   440131009
        Sarecycline-containing product in oral dose form   781652004

SNOMED CT Concept   138875005
  Pharmaceutical / biologic product   373873005
    Medicinal product   763158003
      Medicinal product categorized by therapeutic role   763087004
        Antiacne agent   773929004
          Sarecycline-containing product in oral dose form   781652004

SNOMED CT Concept   138875005
  Pharmaceutical / biologic product   373873005
    Medicinal product   763158003
      Medicinal product categorized by disposition   766779001
        Sarecycline-containing product   781650007
          Sarecycline-containing product in oral dose form   781652004

ancestors
sorted most to least specific
cpt crosswalks

Rules-based maps relating CPT® codes to and from SNOMED CT® clinical concepts.  Forward and backward mapping allows for easy transition between code sets. Map-A-Code crosswalk tool easily crosswalks multiple codes between the code sets.

Access to this feature is available in the following products:
  • CPT® to SNOMED Crosswalks

demo
request yours today
subscribe
start today
newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.